Loading
Latest filing published 12 Aug 2026 for Corbus Pharmaceuticals Holdings, Inc., €22k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Nishant C. Saxena on record concern Corbus Pharmaceuticals Holdings, Inc. Between 21 May 2026 and 11 August 2026, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 1 purchase, €22k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.
Most recently, on 12 August 2026, the filings show an open-market purchase worth €22k in Corbus Pharmaceuticals Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations